Conquering Diseases

Study Of An Investigational Drug For Mild To Moderate Covid-19

Description

Seeking men and women with mild to moderate COVID-19 infection who have tested positive within the last 3 days for a study of an investigational drug that has been approved for use in other countries for the flu and other viral illnesses.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine).

What we're hoping for

We are studying whether a drug that has been approved for use in other countries for the flu and other viral illnesses is safe and effective in reducing the severity of COVID-19 in adults with mild to moderate symptoms.

Additional Information

ClinicalTrials.gov Identifier: NCT04600895

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

Melissa  Adams

508-856-4676

melissa.adams@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989